Sign In
Buy ADAP
$0.0549
+0 (+0%)
At Close: Feb 20, 2026
Is Adaptimmune Therapeutics a Buy?
10:30am, Friday, 12'th Jun 2020
Cancer is one of the most challenging conditions for investigational therapies to target because malignant cells are frequently able to disguise themselves as healthy cells, thereby surpassing detecti
Youngsters reap rewards for their kindness during lockdown
10:07am, Wednesday, 10'th Jun 2020
As part of mental health awareness week and this year’s campaign of #bekind, TCR Tiverton Community Radio showcased children in the community who had showed kindness, caring and coping during the CO
Arrowsic closes Sewall Pond Conservation Area due to heavy use amid pandemic
01:45am, Wednesday, 10'th Jun 2020
The Arrowsic Board of Selectmen will review the decision at their bi-weekly meetings and vote to either open the conservation area or keep it closed.
Why Adaptimmune Therapeutics Stock Crushed It in May
02:30pm, Monday, 08'th Jun 2020
Adaptimmune Therapeutics (NASDAQ: ADAP), a clinical-stage biotech, saw its shares gain an astounding 230% over the month of May, according to data from S&P; Global Market Intelligence. What appears
Transformational Challenge Nuclear Reactor: Microreactor Built Using 3D Printing
12:04pm, Sunday, 07'th Jun 2020
Scientists at the Department of Energy Manufacturing Demonstration Facility at Oak Ridge National Laboratory have their eyes on the prize: the Transformational Challenge Reactor, or TCR, a microreacto
This Is Exactly the Wrong Time for Another High-Speed Train Boondoggle | National Review
08:26pm, Friday, 05'th Jun 2020
Today, the truly gullible are being lured by those with a new sales pitch: “Boy, have I got a high-speed rail line for you.”
Gold Interests Point Northward on N. American Markets
08:51pm, Thursday, 04'th Jun 2020
Jun 04, 2020 (Baystreet.ca via COMTEX) --
There's gold in "them, thar markets," as the old saw goes, and with tension in the world, gold stocks tend to...
Adaptimmune Therapeutics plc Announces Closing of Public Offering of American Depositary Shares
02:45pm, Thursday, 04'th Jun 2020
Adaptimmune Therapeutics plc (“Adaptimmune”)(ADAP), a leader in cell therapy to treat cancer, today announced the closing of its previously announced underwritten public offering of its American D
Artax Biopharma Announces Series B Financing Extension to Advance First-in-Class Autoimmune Disease Therapy
02:17pm, Thursday, 04'th Jun 2020
CAMBRIDGE, Mass., June 4, 2020 /PRNewswire via COMTEX/ --
CAMBRIDGE, Mass., June 4, 2020 /PRNewswire/ -- Artax Biopharma, Inc., a biotechnology company...
Gene-edited T cells to treat diabetes inch closer to clinical trials
06:00pm, Wednesday, 03'rd Jun 2020
Scientists at Seattle Children’s Research Institute and the Benaroya Research Institute have engineered T cells that mimic the immunosuppressive properties of regulatory T cells—an approach that t
6 Stocks To Watch: Arena Pharma, Baozun, NIO, Precigen, Sea Limited, Stratasys
12:00am, Wednesday, 03'rd Jun 2020
Stocks Analysis by Harry Boxer covering: SPDR S&P 500, Extreme Networks Inc, DXC Technology Co, Compugen. Read Harry Boxer's latest article on Investing.com
Adaptimmune Announces $11/ADS Pricing; Stock Now Up Over 850% YTD
08:37am, Tuesday, 02'nd Jun 2020
Biopharma Adaptimmune Therapeutics (ADAP) has now announced the pricing of an underwritten public offering of 20,500,000 of its American Depositary Shares (“ADSs”) at a price to the public of $11
Are Options Traders Betting on a Big Move in Adaptimmune Therapeutics (ADAP) Stock?
04:38am, Tuesday, 02'nd Jun 2020
Investors need to pay close attention to Adaptimmune Therapeutics (ADAP) stock based on the movements in the options market lately.
Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares
01:39am, Tuesday, 02'nd Jun 2020
Adaptimmune Therapeutics plc (“Adaptimmune”)(ADAP), a leader in cell therapy to treat cancer, today announced the pricing of an underwritten public offering of 20,500,000 of its American Depositar
Are Options Traders Betting on a Big Move in Adaptimmune Therapeutics (ADAP) Stock?
12:00am, Tuesday, 02'nd Jun 2020
Stocks Analysis by Zacks Investment Research covering: Adaptimmune Therapeutics Plc. Read Zacks Investment Research's latest article on Investing.com
